Delivery Order SPE2DB20D7059-SPE2DB25FQMK8
Award Date 8/1/25
Potential Completion Date 8/4/25
Potential Value $4.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $3,077.32 to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg, an anti-nausea medication commonly used in medical settings. The contract, awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $26,378.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg, an anti-nausea medication commonly used in military and veteran healthcare settings. The contract, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The product will...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,203.56 for 500 tablets of Ondansetron HCL 4 mg, an anti-nausea medication commonly used in military and federal healthcare settings. Awarded on July 27, 2025, with an ultimate completion date of July 28, 2025, this firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The...
- The Defense Logistics Agency awarded a delivery order valued at $2,849.46 to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg, with an ultimate completion date of August 11, 2025. This non-competitive delivery order was issued on August 8, 2025, with firm fixed pricing. The award represents a routine pharmaceutical procurement through AmerisourceBergen's established supply chain, with performance to be executed at the company's Conshohocken, Pennsylvania location. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,938.52 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This competitively awarded, firm fixed-price contract is scheduled for completion by August 4, 2025, with performance at the contractor's corporate headquarters in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,074.56 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (30-unit packages), an anti-nausea medication commonly used in military and federal healthcare settings. This firm fixed-price contract represents a competitively awarded delivery order with no set-aside designation, with performance scheduled for completion by July 24, 2025. The product will be supplied from AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Ondansetron ODT 4 mg, a commonly used anti-nausea medication, under a firm fixed-price contract valued at $1,842.70. The contract, which became effective on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order was competitively awarded...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg, a commonly prescribed anti-nausea medication, with a contract ceiling value of $28,004.90. The contract, awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of 500 tablets of Ondansetron HCL 4 mg, an anti-nausea medication commonly used in military and federal healthcare settings. The contract was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, and carries a ceiling value of $43,367.61. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded among qualified...
- The Defense Logistics Agency awarded a delivery order valued at $3,759.95 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets in quantities of 30, with an ultimate completion date of August 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be performed from the contractor's facility...